BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 50 filers reported holding BIOTA PHARMACEUTIALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $526,000 | -22.8% | 350,776 | 0.0% | 0.13% | +12.1% |
| Q4 2015 | $681,000 | -2.0% | 350,776 | 0.0% | 0.12% | -17.1% |
| Q3 2015 | $695,000 | -4.3% | 350,776 | 0.0% | 0.14% | +9.4% |
| Q2 2015 | $726,000 | -10.0% | 350,776 | 0.0% | 0.13% | -24.3% |
| Q1 2015 | $807,000 | -17.3% | 350,776 | -19.5% | 0.17% | -11.1% |
| Q4 2014 | $976,000 | -9.4% | 435,900 | 0.0% | 0.19% | -15.2% |
| Q3 2014 | $1,077,000 | -13.3% | 435,900 | 0.0% | 0.22% | +14.3% |
| Q2 2014 | $1,242,000 | -53.4% | 435,900 | 0.0% | 0.20% | -52.5% |
| Q1 2014 | $2,663,000 | – | 435,900 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,486,711 | $6,764,000 | 0.42% |
| SENZAR ASSET MANAGEMENT, LLC | 1,910,476 | $3,706,323,000 | 0.41% |
| TOWERVIEW LLC | 160,000 | $310,000 | 0.16% |
| BVF INC/IL | 350,776 | $681,000 | 0.12% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 218,177 | $423,000 | 0.05% |
| EAGLE GLOBAL ADVISORS LLC | 272,072 | $528,000 | 0.02% |
| Spark Investment Management LLC | 70,500 | $136,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 203,170 | $394,000 | 0.01% |
| JW Asset Management, LLC | 8,611 | $17,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 147,281 | $286,000 | 0.01% |